CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
2020 · Trials · 15 citations
https://doi.org/10.1186/s13063-019-3643-6
J
Jessica Kendall
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
140
Citations
6
h-index
4
i10-index
Jessica Kendall is an academic researcher from University of Leeds. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Radiopharmaceutical Chemistry and Applications & Protein Degradation and Inhibitors. The author has an h-index of 6, co-authored 21 publications.
ORCID: 0000-0003-2884-4849Papers by this author
worksIxazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results
2022 · Blood Cancer Journal · 14 citations
https://doi.org/10.1038/s41408-022-00626-4
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01671-2
3513 ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104)
2025 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(25)01767-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat